These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2779388)

  • 1. Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease.
    Shah A; Morgan G; Rose JD; Fifield R; Rhodes J
    Med Lab Sci; 1989 Jan; 46(1):79-80. PubMed ID: 2779388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mean platelet volume (MPV) in Crohn's disease patients].
    Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
    Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
    Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
    Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood protein concentrations--are they parameters of disease activity in Crohn's disease?].
    Meryn S; Lochs H; Bettelheim P; Sertl K; Mulak K
    Leber Magen Darm; 1985 Jul; 15(4):160-4. PubMed ID: 3877229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet count: a simple measure of activity in Crohn's disease.
    Harries AD; Fitzsimons E; Fifield R; Dew MJ; Rhoades J
    Br Med J (Clin Res Ed); 1983 May; 286(6376):1476. PubMed ID: 6405846
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
    Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
    Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the ratio of orosomucoid and prealbumin values as an indicator of the activity of Crohn's disease].
    Richter J; Bitter J; Král V; Zuvacová J
    Cas Lek Cesk; 1982 Dec; 121(48):1493-4. PubMed ID: 7151117
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor/cachectin in Crohn's disease. Relation of serum concentration to disease activity.
    Sategna-Guidetti C; Pulitanò R; Fenoglio L; Bologna E; Manes M; Camussi G
    Recenti Prog Med; 1993 Feb; 84(2):93-9. PubMed ID: 8465094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability test as a predictor of clinical course in Crohn's disease.
    D'Incà R; Di Leo V; Corrao G; Martines D; D'Odorico A; Mestriner C; Venturi C; Longo G; Sturniolo GC
    Am J Gastroenterol; 1999 Oct; 94(10):2956-60. PubMed ID: 10520851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total parenteral nutrition modifies the acute phase response to Crohn's disease.
    Carlson GL; Gray P; Barber D; Shaffer JL; Mughal M; Irving MH
    J R Coll Surg Edinb; 1994 Dec; 39(6):360-4. PubMed ID: 7532715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocytes as an indicator of activity in Crohn's disease treated with total parenteral and/or enteral nutrition].
    Bures J; Horácek J; Pecka M; Tichý M; Cervenka B; Král B; Fixa B; Komárková O; Pidrman V
    Vnitr Lek; 1994 Feb; 40(2):84-8. PubMed ID: 8140766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of total parenteral nutrition on serum concentrations of eight proteins in Crohn's disease.
    Jacobson S; Kallner A
    Am J Gastroenterol; 1984 Jul; 79(7):501-5. PubMed ID: 6430066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet count in patients with Crohn's disease.
    Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1895-6. PubMed ID: 6407620
    [No Abstract]   [Full Text] [Related]  

  • 20. Determining disease activity in inflammatory bowel disease.
    Cooke WT; Prior P
    J Clin Gastroenterol; 1984 Feb; 6(1):17-25. PubMed ID: 6699391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.